IDH1 and central nervous system cancer: Survival analyses further revealed that elevated PDPN expression was associated with worse overall survival specifically in the IDH-wildtype subgroup, whereas no significant prognostic effect of PDPN expression was observed in IDH-mutant gliomas (Fig 2D).